A case report of a chronic migraine patient treated with three different anti-CGRP monoclonal antibodies: which parameters better represent the efficacy?

Uzun, Sena; Frejvall, Ulf; Özkaya-Sahin, Gülsen; Sahin, Gürdal

Uzun, Sena; Frejvall, Ulf; Özkaya-Sahin, Gülsen; Sahin, Gürdal.

Afiliación

Uzun S; SkåNeuro Neurology Clinic, Lund, Sweden.
Frejvall U; Department of Clinical Sciences of Malmö and Lund, Lund University, Lund, Sweden.
Özkaya-Sahin G; SkåNeuro Neurology Clinic, Lund, Sweden.
Sahin G; Department of Laboratory Medicine, Section of Clinical Microbiology, Lund, Sweden.

Front Neurol ; 14: 1176816, 2023.

Article en En | MEDLINE | ID: mdl-37213912

Palabras clave

anti-CGRP monoclonal antibodies; case report; chronic migraine; erenumab; fremanezumab; galcanezumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Neurol Año: 2023 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google